Of the 47 pregnant study participants, most were vaccinated and only two stopped taking nirmatrelvir and ritonavir because of side effects, according to a study published Nov. 29 in JAMA.
There were no reported complications with the drug combination, but there was a higher prevalence of cesarean section deliveries than expected. After taking the two drugs, 12 study participants had C-sections, nine of which were planned.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
